Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Schrodinger, Inc. reported Fiscal year ending December 31, 2023 results: revenue Software revenue growth expected to be in the range of 13 to 17 percent; Drug discovery revenue expected to range from $. Guidance initiated.
- Period
- Fiscal year ending December 31, 2023
- Revenue
- Software revenue growth expected to be in the range of 13 to 17 percent; Drug discovery revenue expected to range from $
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
• Software revenue growth is expected to be in the range of 13 to 17 percent • Drug discovery revenue is expected to range from $70 million to
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Schrodinger, Inc. reported Twelve months ended December 31, 2022 results: revenue Total revenue $181.0 million, net income Net loss $(149.2) million.
- Period
- Twelve months ended December 31, 2022
- Revenue
- Total revenue $181.0 million
- Net income
- Net loss $(149.2) million
- Result
- reported results
Exact text from the filing
Total revenue for the full year increased 31% to $181.0 million, compared to $137.9 million for 2021. • Software revenue for the full year 2022 increased 20% to $135.6 million, compared to $113.2 million for 2021, with multi-year agreements making a similar contribution to reported revenue to the contribution in 2021 and 2020. • Drug discovery revenue for the full year was $45.4 million for the full year 2022, compared to $24.7 million for 2021. • Software gross margin was 78% for the full year, compared to 77% for 2021. • Operating expenses were $247.8 million for the full year, compared to $177.1 million for 2021. • Other expense, which includes gains/loss on equity investments, changes in fair value of such investments and interest income/expense, was $2.3 million for the full year, compared to other income of $10.6 million for 2021. • Net loss for the full year was $149.2 million, compared to $101.2 million for 2021.
View on SEC.gov